Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Where's a pumper when you....

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Jan 26, 2022 8:49am

107 Views

Post# 34361500

RE:Where's a pumper when you....

Did you actually read my post? I don't think you will find the word news in their. Don't distort what I say.

Since you seem to be my official antigonist nothing I say to you will matter. But for anyone else reading this I have never made anything up.

I may be wrong on some things but I don't play that game. I have more important things to do then be a hall monitor on peoples posts all day.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale